Update on morphea: Part I. Epidemiology, clinical presentation, and pathogenesis
Top Cited Papers
- 28 February 2011
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 64 (2), 217-228
- https://doi.org/10.1016/j.jaad.2010.05.045
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Distinct Autoimmune Syndromes in MorpheaArchives of Dermatology, 2009
- “Borrelia-associated early-onset morphea”: A particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies?: Results of a cohort analysis and presentation of three casesJournal of the American Academy of Dermatology, 2009
- Neurologic manifestations of localized sclerodermaNeurology, 2008
- Drug-induced morphea: Report of a case induced by balicatib and review of the literatureJournal of the American Academy of Dermatology, 2008
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008
- Ocular involvement in children with localised scleroderma: a multi-centre studyBritish Journal of Ophthalmology, 2007
- Disabling pansclerotic morphea: Clinical presentation in two adultsJournal of the American Academy of Dermatology, 2005
- Localized scleroderma in breast cancer patients treated with supervoltage external beam radiation: Radiation port sclerodermaJournal of the American Academy of Dermatology, 1996
- Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North AmericaJournal of the American Academy of Dermatology, 1995
- Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea)Journal of the American Academy of Dermatology, 1995